Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer

Table 2 Clinicopathological findings according to neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio

Variable	NLR < 3.0	NLR ≥ 3.0	P value	PLR < 160	PLR ≥ 160	P value
	(n = 1086)	(n = 782)		(n = 973)	(n = 894)
T stage			< 0.001			< 0.001
T1	112	39		112	39
T2	171	91		159	102
T3	668	498		579	587
T4	48	59		41	66
Unknown	87	95		82	100
N stage			0.854			0.443
N0	589	434		543	480
N1	289	201		257	232
N2	196	138		164	170
Unknown	12	9		9	12
Lymphatic invasion			0.421			0.446
Yes	349	253		311	291
No	587	391		524	453
Unknown	150	138		138	150
Vascular invasion			0.243			0.011
Yes	193	149		160	182
No	742	496		675	562
Unknown	151	137		138	150
Peri-neural invasion			0.045
Yes	168	142		141	169	0.004
No	767	502		693	575
Unknown	151	138		139	150

NLR: Neutrophil-to-lymphocyte-ratio; PLR: Platelet-to-lymphocyte-ratio.